Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Men who are treated for prostate cancer with hormone-targeted therapy have a higher risk of developing kidney problems, a new study suggests. The treatment, known as androgen deprivation therapy, lowers the risk of death among men with advanced, aggressive prostate cancer.
Hey, check out all the research scientist jobs. Post your resume today!
